Huron Consulting poised to hit fresh record ahead of S&P SmallCap addition
HURN•Huron Consulting shares rose 4.5% premarket after the company was set to join the S&P SmallCap 600, replacing Supernus Pharmaceuticals effective November 2. An analyst estimated passive funds would need to buy 2.1 million Huron shares, equivalent to nearly eight days of buying demand.
1. Index addition announced
Huron Consulting Group shares rose 4.5% to $202 premarket Friday after S&P Dow Jones Indices announced the company would join the S&P SmallCap 600 effective Monday, November 2, replacing Supernus Pharmaceuticals. Huron had risen about 5.5% Thursday to a record closing high of $193.35.
2. Estimated fund demand
Stephens analyst Melissa Roberts said she expects passive funds will need to purchase 2.1 million Huron shares, implying nearly eight days of buying demand. Huron has about 15.9 million shares outstanding and a roughly $3 billion market capitalization.
3. Shares and analyst ratings
The Chicago-based company's stock has rallied from its 2026 intraday low of $84.88 on June 22 and was up about 12% year to date. Three analysts rate the stock “strong buy” and two rate it “buy”; the median price target was $214, up from $194 a month earlier, per LSEG.
